Trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy

Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup